Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice

References

• Weetman AP, McGregor AM, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol (Oxf) 1984; 21: 163–172
   PubMed Web of Science ®Google Scholar
• McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 1980; 303: 302–307
   PubMed Web of Science ®Google Scholar
• Rennie DP, McGregor AM, Keast D, Weetman AP, Foord SM, Dieguez C, Williams ED, Hall R. The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat. Endocrinology 1983; 112: 326–330
   PubMed Web of Science ®Google Scholar
• Davies TF, Weiss I, Gerber MA. Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo. J Clin Invest 1984; 73: 397–404
   PubMed Web of Science ®Google Scholar
• Wang P, Sun S-H, Silver PB, Chan C-C, Agarwal RK, Wiggert B, Kohn LD, Jamieson GA, Jr, Caspi RR. Methimazole protects from experimental autoimmune uveitis (EAU) by inhibiting antigen presenting cell function and reducing antigen priming. J Leukoc Biol 2003; 73: 57–64
   Google Scholar
• Singer DS, Kohn LD, Zinger H, Mozes E. Methimazole prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 1994; 153: 873–880
   PubMedGoogle Scholar
• Aguayo J, Iitaka M, Row VV, Volpe R. Studies of HLA-DR expression on cultured human thyrocytes: Effect of antithyroid drugs and other agents on interferon-γ-induced HLA-DR expression. J Clin Endocrinol Metab 1988; 66: 903–908
   PubMed Web of Science ®Google Scholar
• Bodolay E, Suranyi P, Juhasz F, Stenszky V, Balaz C, Farid NR. Methimazole blocks Graves' IgG but not interferon-γ HLA-DR expression by thyroid cells. Immunol Lett 1988; 18: 167–172
   Google Scholar
• Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: Opposite effects of interferon and methimazole. Endocrinology 1998; 139: 290–302
   PubMedGoogle Scholar
• Davies TF, Yang C, Platzer M. The influence of antithyroid drugs and iodine on thyroid cell MHC class II antigen expression. Clin Immunol 1989; 31: 125–135
   Google Scholar
• Saji M, Moriarty J, Ban T, Singer DS, Kohn LD. Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole and iodide as well as interferon. J Clin Endocrinol Metab 1992; 75: 871–878
   PubMed Web of Science ®Google Scholar
• Mozes E, Zinger H, Kohn LD, Singer DS. Spontaneous autoimmune disease in (NZB × NZW) F1 mice is ameliorated by treatment with methimazole. J Clin Immunol 1998; 18: 106–112
   PubMedGoogle Scholar
• Mellman I, Steinman RM. Dendritic cells: Specialized and regulated antigen processing machines. Cell 2001; 106: 255–258
   PubMed Web of Science ®Google Scholar
• Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large number of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693–1702
   PubMed Web of Science ®Google Scholar
• Kita-Furuyama M, Nagayama Y, Pichurin P, McLachlan SM, Rapoport B, Eguchi K. Dendritic cells infected with adenovirus expressing the thyrotropin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol 2003; 131: 234–240
   PubMedGoogle Scholar
• Mizutori Y, Saitoh O, Eguchi K, Nagayama Y. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice. J Autoimmun 2006; 26: 32–36
   PubMed Web of Science ®Google Scholar
• Chen C-R, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM. The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 2003; 111: 1897–1904
   PubMed Web of Science ®Google Scholar
• Nagayama Y, Kita-Furuyama M, Nakao K, Ando T, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing thyrotropin receptor. J Immunol 2002; 168: 2789–2794
   PubMed Web of Science ®Google Scholar
• Okada N, Masunaga Y, Okada Y, Iiyama S, Mori N, Tsuda T, Matsubara A, Mizuguchi H, Hayakawa T, Fujita T, Yamamoto A. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional and RGD fiber-mutant adenovirus vector. Cancer Gene Ther 2003; 10: 421–431
   Google Scholar
• Hirschowitz EA, Weaver JD, Hidalgo GE, Doherty DE. Murine dendritic cells infected with adenovirus vectors show signs of activation. Gene Ther 2000; 7: 1112–1120
   PubMed Web of Science ®Google Scholar
• Lindstedt M, Johansson-Lindbom B, Carl AK, Borrebaeck CAK. Global reprogramming of dendritic cells in response to a concerted action of infammatory mediators. Int Immunol 2002; 14: 1203–1213
   PubMed Web of Science ®Google Scholar
• Kaithamana S, Fan J, Osuga Y, Liang SG, Prabhakar BS. Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol 1999; 163: 5157–5164
   PubMed Web of Science ®Google Scholar
• Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity. Lancet 1983; 2: 1111–1115
   PubMed Web of Science ®Google Scholar
• Battifora M, Pesce G, Paolieri F, Fiorino N, Giordano C, Riccio AM, Torre G, Olive D, Bagnasco M. B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. J Clin Endocrinol Metab 1998; 83: 4130–4139
   PubMed Web of Science ®Google Scholar
• Li Y-S, Kanamoto N, Hataya Y, Moriyama K, Hiratani H, Nakao K, Akamizu T. Transgenic mice producing major histocompatibility complex class II molecules on thyroid cells do not develop apparent autoimmune thyroid diseases. Endocrinology 2004; 145: 2524–2530
   PubMedGoogle Scholar
• Pittman JA, Beschi RJ, Smitherman TC. Methimazole: Its absorption and excretion in man and tissue distribution in rats. J Clin Endocrinol Metab 1971; 33: 182–185
   PubMed Web of Science ®Google Scholar
• Jansson R, Dahlberg PA, Johansson H, Lindstrom B. Intrathyroidal concentrations of methimazole in patients with Graves' disease. J Clin Endocrinol Metab 1983; 57: 129–132
   PubMed Web of Science ®Google Scholar
• Balazs C, Kiss E, Leovey A, Farid NR. The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals. Clin Endocrinol (Oxf) 1986; 25: 7–16
   PubMedGoogle Scholar
• Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid 2000; 10: 527–532
   PubMed Web of Science ®Google Scholar